Review: taking Vancomycin hydrochloride and Meropenem together


Summary

Drug interactions are reported among people who take Vancomycin hydrochloride and Meropenem together. This review analyzes the effectiveness and drug interactions between Vancomycin hydrochloride and Meropenem. It is created by eHealthMe based on reports of 2,554 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Vancomycin Hydrochloride

Vancomycin hydrochloride has active ingredients of vancomycin hydrochloride. It is often used in staphylococcal infection. (latest outcomes from Vancomycin hydrochloride 3,176 users)

Meropenem

Meropenem has active ingredients of meropenem. It is often used in pneumonia. (latest outcomes from Meropenem 7,733 users)

On Sep, 16, 2016

2,554 people who take Vancomycin Hydrochloride, Meropenem are studied.


Number of reports submitted per year:

Vancomycin hydrochloride and Meropenem drug interactions.

Drug effectiveness over time:

Vancomycin Hydrochloride:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Meropenem:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Vancomycin Hydrochloride:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)
Meropenem:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Vancomycin Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Meropenem:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • pyrexia
  • pneumonia
  • febrile neutropenia
  • sepsis
  • diarrhoea
  • neutropenia
  • multi-organ failure
  • respiratory failure
  • anaemia
  • gastrointestinal haemorrhage
1 - 6 months:
  • pyrexia
  • toxic epidermal necrolysis
  • hepatic function abnormal
  • pancytopenia
  • engraft failure
  • liver disorder
  • pneumonia
  • diarrhoea
  • febrile neutropenia
  • chronic graft versus host disease
6 - 12 months:
  • abnormal loss of weight
  • asthenia
  • contusion
  • depressed level of consciousness
  • tremor
2 - 5 years:
  • abdominal pain upper
  • anaemia
  • ascites
  • cachexia
  • cardiovascular insufficiency
  • coma
  • drug resistance
  • electrolyte imbalance
  • enterococcus test positive
  • hepatic failure
not specified:
  • pyrexia
  • sepsis
  • multi-organ failure
  • drug ineffective
  • pneumonia
  • renal failure acute
  • respiratory failure
  • hypotension
  • neutropenia
  • septic shock

Most common drug interactions by gender *:

female:
  • pyrexia
  • sepsis
  • febrile neutropenia
  • multi-organ failure
  • pneumonia
  • neutropenia
  • diarrhoea
  • respiratory failure
  • pleural effusion
  • renal failure acute
male:
  • pyrexia
  • pneumonia
  • sepsis
  • multi-organ failure
  • renal failure acute
  • respiratory failure
  • neutropenia
  • hypotension
  • febrile neutropenia
  • thrombocytopenia

Most common drug interactions by age *:

0-1:
  • pyrexia
  • anaemia
  • thrombocytopenia
  • cardiac failure
  • pulmonary haemorrhage
  • cardiac arrest
  • gastrointestinal haemorrhage
  • mitral valve incompetence
  • multi-organ failure
  • blood urea abnormal
2-9:
  • pyrexia
  • diarrhoea
  • respiratory failure
  • nausea
  • abdominal pain
  • drug ineffective
  • hypotension
  • vomiting
  • headache
  • somnolence
10-19:
  • pyrexia
  • diarrhoea
  • neutropenia
  • drug ineffective
  • pneumonia
  • septic shock
  • hypertension
  • cystitis haemorrhagic
  • engraft failure
  • hepatic function abnormal
20-29:
  • pyrexia
  • renal failure
  • respiratory failure
  • eosinophilia
  • infection
  • multi-organ failure
  • venoocclusive liver disease
  • staphylococcal sepsis
  • drug ineffective
  • brain stem haemorrhage
30-39:
  • pyrexia
  • sepsis
  • multi-organ failure
  • neutropenia
  • hypotension
  • pulmonary embolism
  • rash
  • anaemia
  • renal failure acute
  • liver function test abnormal
40-49:
  • pyrexia
  • neutropenia
  • diarrhoea
  • febrile neutropenia
  • sepsis
  • rash maculo-papular
  • multi-organ failure
  • alanine aminotransferase increased
  • pleural effusion
  • abdominal pain
50-59:
  • sepsis
  • pneumonia
  • respiratory failure
  • renal failure acute
  • pyrexia
  • thrombocytopenia
  • gastrointestinal haemorrhage
  • liver function test abnormal
  • pancytopenia
  • septic shock
60+:
  • pneumonia
  • pyrexia
  • sepsis
  • febrile neutropenia
  • renal failure acute
  • multi-organ failure
  • respiratory failure
  • toxic epidermal necrolysis
  • platelet count decreased
  • thrombocytopenia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Vancomycin hydrochloride and Meropenem?

Can you answer these questions?

More questions for: Vancomycin hydrochloride, Meropenem

You may be interested in these reviews

More reviews for: Vancomycin hydrochloride, Meropenem

On eHealthMe, Vancomycin hydrochloride (vancomycin hydrochloride) is often used to treat staphylococcal infection. Meropenem (meropenem) is often used to treat pneumonia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.